Key clinical point: Certain antidiabetes medications may protect against dementia.

Major finding: Type 2 diabetes patients whose treatment regimen included an SGLT2 inhibitor were 62% less likely to develop dementia.

Study details: This Danish national case control registry study included 11,619 type 2 diabetes patients who received a dementia diagnosis and 46,476 matched type 2 diabetes patients without dementia.

Disclosures: The presenter reported having no financial conflicts of interest regarding the study, which was funded by the Danish Diabetes Foundation, the Danish Medical Association, and other foundations.